The Mounjaro single-dose pen: what it is, how it differs, and what that means for you

Both the four-dose and single-dose Mounjaro pens contain the same active medicine, tirzepatide, at the same UK-licensed strengths (2.5 mg through to 15 mg).
Each single-dose pen is pre-filled and pre-set, so no dose-dialling is required before injecting — the strength is fixed at manufacture.
Storage requirements are the same across both formats: refrigerated at 2–8°C, with a limited room-temperature window detailed in the Patient Information Leaflet.
The pen format used during your treatment is confirmed by your prescriber based on clinical suitability, supply, and your dose at the time.

Mounjaro is available in the UK in two pen formats: the familiar four-dose KwikPen, and a single-dose version that delivers one pre-set injection before being disposed of. Both contain exactly the same tirzepatide medicine, at the same licensed strengths. Which format you use is a clinical decision, not a personal preference you make at checkout — a prescriber will confirm what's right for your treatment at each stage. These are prescription-only medicines, so a clinical assessment comes before any pen lands in your hands. If you're trying to work out how the two formats compare, or simply want to understand what a single-dose Mounjaro pen actually is before speaking to a clinician, this page covers the facts.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Choosing the right Mounjaro pen format: the factors that actually matter

The decision you're probably facing, and why format alone doesn't drive it

A lot of people encounter the term "single-dose pen" when they're partway through treatment, often because their usual pen format is temporarily unavailable or because their prescriber has moved them to a different dose. There's a persistent misconception that the single-dose version is somehow a different medicine, or a weaker product. It isn't. Both formats are the same Mounjaro (tirzepatide), made by Eli Lilly, licensed in the UK for weight management. The distinction is purely practical: one pen covers four weekly injections; the other covers one. That's the extent of the clinical difference.

What actually matters when your prescriber considers pen format is continuity of treatment at the right strength, not the physical casing. If you're on 5 mg, your prescriber is thinking about whether 5 mg is still the right dose for you, not about which version of the 5 mg pen to reach for. The guidance on Mounjaro dosing explains how titration works more broadly, but the short answer is: format follows the clinical plan, not the other way round.

That said, there are a few real-world factors worth understanding before you speak to a clinician.

How the single-dose pen works in practice

The single-dose Mounjaro pen is pre-filled with a single weekly dose of tirzepatide, and the strength is set at the point of manufacture. There is no dial to adjust. You inject, and the pen is finished, ready to go into a sharps container. That simplicity is genuinely useful for some people, particularly those who find the four-dose pen's mechanism less intuitive, or who are injecting somewhere that makes careful handling of a multi-dose device awkward.

Injection technique is essentially the same regardless of format: subcutaneous injection into the abdomen, thigh, or upper arm, with sites rotated each week. The step-by-step guide to injecting with the single-dose pen covers the technique in detail. Storage is refrigerated until use; the exact window for how long the pen may be kept at room temperature before injection is set out in the Patient Information Leaflet, and that's the definitive source, your prescriber or pharmacist can clarify this too.

One practical note: because each pen covers one week rather than four, you'll typically receive more physical items per month if you're using the single-dose format. That can feel like more to keep track of, but it also means there's no part-used pen to manage between injections.

Which strengths are available in the single-dose format?

Mounjaro is licensed in the UK at six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, as confirmed in the BNF's tirzepatide monograph. The single-dose pen exists across this range. Treatment always begins at 2.5 mg, that first pen's purpose is settling your system into the medicine, not producing immediate weight loss. From there, a prescriber typically steps the dose upward at roughly four-week intervals, depending on how you're tolerating treatment.

If you want a fuller picture of what each dose step involves, the overview of Mounjaro pen doses walks through the titration schedule. For the 5 mg step specifically (the one most people reach after their first month) there's also a dedicated page on the 5 mg Mounjaro pen that covers what to expect at that stage.

The format question at each strength is genuinely a supply and clinical conversation. Your prescriber won't withhold a dose increase because one format is unavailable; they'll work with what the licensed supply chain offers at that point.

How to access the right Mounjaro pen for your treatment

Mounjaro is a prescription-only medicine. In the UK, the lawful route is a prescription issued following a clinical assessment, no clinical review, no prescription, no legitimate pen. The full Mounjaro overview explains eligibility (broadly, BMI of 30 or above, or 27 or above with a weight-related health condition, though a prescriber assesses the whole picture).

Through a regulated private pharmacy like ours, the process is: a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, followed by ID and weight verification. Once approved, treatment dispatches the same day for free next-working-day delivery via DPD. Our GPhC pharmacy registration is publicly verifiable at the GPhC register, that link takes you directly to our premises record. If you've seen Mounjaro offered at prices that seem surprisingly low or from a seller who asks nothing clinical, that's a serious red flag; counterfeit pens have caused real harm in the UK, as the MHRA has warned publicly on multiple occasions.

On the question of cost, the Mounjaro access page sets out how private pricing works and what a legitimate price should include. For context on what the overall treatment landscape looks like, our weight-loss treatments overview is a good place to start before booking a consultation.

If you're ready to find out whether Mounjaro is right for you, start your free consultation with our clinical team today.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions